Who Buys Omeprazole from India — 2858 Importers Behind a $635.6M Market
India's omeprazole import market is served by 2858 active buyers who collectively imported $635.6M across 15,000 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 8.6% market share, followed by SUN PHARMA CANADA INC. and CIPLAMEDICA PHARMACEUTICAL INDUSTRI. The top 5 buyers together control 35.4% of total import value, reflecting a moderately competitive buyer landscape.
Top Omeprazole Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading omeprazole importer from India, holding a 8.6% share of the $635.6M market across 15,000 shipments from 2858 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), SUN PHARMA CANADA INC. (CANADA), CIPLAMEDICA PHARMACEUTICAL INDUSTRI (YEMEN), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), DELTA IMPORT-EXPORT MEDICAL CO LTD (VIETNAM) — collectively control 35.4% of total import value.
Top Omeprazole Buyers & Importers
Ranked by import value · 2858 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | $54.7M | 5 | 8.6% |
| 2 | SUN PHARMA CANADA INC.CANADA ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTOMEPRAZOLE DR CAP 40MG 1000ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $53.8M | 5 | 8.5% |
| 3 | CIPLAMEDICA PHARMACEUTICAL INDUSTRIYEMEN LOMAC 20 CAPSULES | $50.0M | 5 | 7.9% |
| 4 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES LOMAC 20 CAPSULESOMEPRAZOLE DR CAP 40MG 1000ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $41.1M | 5 | 6.5% |
| 5 | DELTA IMPORT-EXPORT MEDICAL CO LTDVIETNAM SOMEXWELL-40OMICAP-20 (10LOMAC 20 CAPS .. (IN | $25.5M | 5 | 4.0% |
| 6 | MYLAN PHARMACEUTICALS ULC,CANADA OMEPRAZOLE DR CAP 40MG 1000OMEPRAZOLE LYOPHILISATE FOR PREPARATIONOMITOX GASTRO CAPSULES 20MG (OMEPRAZOLE | $24.3M | 5 | 3.8% |
| 7 | GLENMARK PHARMACEUTICALS INC., USAUNITED STATES OMEPRAZOLE DR CAP 40MG 1000ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $17.8M | 5 | 2.8% |
| 8 | M/S. SUN PHARMA ANZ PTY LTDAUSTRALIA SOMEXWELL-40ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTOMICAP-20 (10 | $16.5M | 5 | 2.6% |
| 9 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES OMEPRAZOLE DR CAP 40MG 1000 | $12.8M | 5 | 2.0% |
| 10 | DR REDDYS LABORATORIES INCUNITED STATES LOMAC 20 CAPSULESSOMEXWELL-40OMICAP-20 (10 | $10.6M | 5 | 1.7% |
| 11 | DR. REDDYS LABORATORIES, INCUNITED STATES SOMEXWELL-40OMICAP-20 (10OMEPRAZOLE DR CAP 40MG 1000 | $10.6M | 5 | 1.7% |
| 12 | GLENMARK PHARMACEUTICALS INC USAUNITED STATES OMEPRAZOLE DR CAP 40MG 1000ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $9.7M | 5 | 1.5% |
| 13 | YUSEN LOGISTICS BENELUXBELGIUM ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | $9.1M | 5 | 1.4% |
| 14 | NUTRI-PHARMA USA COMPANY LIMITEDVIETNAM SOMEXWELL-40OMICAP-20 (10LOMAC 20 CAPS .. (IN | $8.3M | 5 | 1.3% |
| 15 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES OMEPRAZOLE DR CAP 40MG 1000 | $6.8M | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Omeprazole — and from which countries?
Flow of Omeprazole exports from India: each country's share and the named importers behind the numbers
Omeprazole — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $165.2M through 1,393 shipments. This represents a market share of 26.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $41.1M (24.9% of country's total business)
• GLENMARK PHARMACEUTICALS INC., USA - $17.8M (10.8% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES - $12.8M (7.7% of country's total business)
• DR REDDYS LABORATORIES INC - $10.6M (6.4% of country's total business)
• DR. REDDYS LABORATORIES, INC - $10.6M (6.4% of country's total business)
• Rest of United States's importers - $72.3M (43.8% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $118.6K, indicating premium pricing strategy compared to the market average of $42.4K.
United States is a key market for Omeprazole imports, representing 26.0% of total trade value.
2Canada
Canada emerges as the second largest importing country, achieving a total trade value of $85.9M through 14 shipments. This represents a market share of 13.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• SUN PHARMA CANADA INC. - $53.8M (62.6% of country's total business)
• MYLAN PHARMACEUTICALS ULC, - $24.3M (28.3% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $6.1M, indicating premium pricing strategy compared to the market average of $42.4K.
Canada is a key market for Omeprazole imports, representing 13.5% of total trade value.
3Belgium
Belgium emerges as the third largest importing country, achieving a total trade value of $64.2M through 459 shipments. This represents a market share of 10.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $54.7M (85.2% of country's total business)
• YUSEN LOGISTICS BENELUX - $9.1M (14.2% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $139.9K, indicating premium pricing strategy compared to the market average of $42.4K.
Belgium is a key market for Omeprazole imports, representing 10.1% of total trade value.
4Yemen
Yemen emerges as the fourth largest importing country, achieving a total trade value of $51.7M through 14 shipments. This represents a market share of 8.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Yemen has a diverse importer base, with their top importers including:
• CIPLAMEDICA PHARMACEUTICAL INDUSTRI - $50.0M (96.7% of country's total business)
Key Insight: Yemen demonstrates strong market positioning with an average shipment value of $3.7M, indicating premium pricing strategy compared to the market average of $42.4K.
Yemen is a key market for Omeprazole imports, representing 8.1% of total trade value.
5Vietnam
Vietnam emerges as the fifth largest importing country, achieving a total trade value of $43.0M through 25 shipments. This represents a market share of 6.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• DELTA IMPORT-EXPORT MEDICAL CO LTD - $25.5M (59.3% of country's total business)
• NUTRI-PHARMA USA COMPANY LIMITED - $8.3M (19.2% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $1.7M, indicating premium pricing strategy compared to the market average of $42.4K.
Vietnam is a key market for Omeprazole imports, representing 6.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Omeprazole buyer market intelligence
1Buyer Segment Analysis
The 2,858 buyers of Omeprazole from India can be categorized into several segments:
1. Distributors: Entities that purchase Omeprazole in bulk to supply to various healthcare providers and retailers. For instance, YUSEN LOGISTICS BENELUX BELGIUM in Belgium, with imports totaling $54.70 million, likely operates as a distributor, facilitating the movement of pharmaceuticals across regions. Distributors typically place large, periodic orders to maintain a steady supply chain.
2. Pharmaceutical Companies: Manufacturers that import Omeprazole either as an active pharmaceutical ingredient (API) or in finished dosage forms for further processing or direct distribution. Companies like SUN PHARMA CANADA INC. ($53.79 million) and CIPLA USA INC. ($41.14 million) fall into this category. Their procurement patterns are aligned with production schedules and market demand forecasts.
3. Government Procurement Agencies: Organizations responsible for acquiring medicines for public healthcare systems, often through tender-based processes. While specific agencies are not listed among the top buyers, countries like Yemen, with significant imports ($50.02 million by CIPLAMEDICA PHARMACEUTICAL INDUSTRI), may involve government tenders. These buyers typically have stringent quality requirements and may place large, infrequent orders based on public health needs.
4. Contract Manufacturers: Firms that produce pharmaceuticals on behalf of other companies, requiring a steady supply of APIs like Omeprazole. Entities such as MYLAN PHARMACEUTICALS ULC in Canada ($24.28 million) and GLENMARK PHARMACEUTICALS INC., USA ($17.78 million) are indicative of this segment. Their purchasing behavior is closely tied to contractual obligations and production timelines.
Country-Specific Import Regulations
TransData Nexus Omeprazole buyer market intelligence
1Country-Specific Import Regulations
United States
1. Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Omeprazole products comply with FDA regulations, including proper labeling and approval for sale in the U.S. market. Repackaging without appropriate country-of-origin marking can lead to misbranding issues.
3. Estimated Timeline for Registration: The FDA's drug approval process can vary, but for generic drugs, it typically takes 10 months under the Generic Drug User Fee Amendments (GDUFA).
4. Import Tariff/Duty for HS 30049034: Pharmaceutical products under this HS code are generally duty-free in the United States.
Canada
1. Regulatory Authority: Health Canada.
2. Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure products meet the Food and Drug Regulations. In cases of drug shortages, Health Canada may permit exceptional importation and sale of drugs not authorized in Canada. (canada.ca)
3. Estimated Timeline for Registration: The standard review process for generic drugs is approximately 180 days.
4. Import Tariff/Duty for HS 30049034: Pharmaceutical products under this HS code are typically duty-free in Canada.
Belgium
1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Importers must hold a Wholesale Distribution Authorization and ensure products comply with European Medicines Agency (EMA) standards.
3. Estimated Timeline for Registration: The EMA's centralized procedure takes up to 210 days, but national procedures may vary.
4. Import Tariff/Duty for HS 30049034: As part of the EU, Belgium applies a common external tariff; however, pharmaceutical products are often exempt from duties.
Yemen
1. Regulatory Authority: Supreme Board of Drugs and Medical Appliances (SBDMA).
2. Import Registration Process: Importers must register pharmaceutical products with the SBDMA, providing documentation on quality, safety, and efficacy.
3. Estimated Timeline for Registration: The process can take several months, depending on the completeness of the application and regulatory workload.
4. Import Tariff/Duty for HS 30049034: Specific tariff information is not readily available; importers should consult local customs authorities.
Vietnam
1. Regulatory Authority: Drug Administration of Vietnam (DAV).
2. Import Registration Process: Importers must obtain a Marketing Authorization from the DAV, ensuring compliance with local regulations.
3. Estimated Timeline for Registration: The registration process typically takes 12 to 24 months.
4. Import Tariff/Duty for HS 30049034: Vietnam applies import duties on pharmaceuticals; specific rates should be confirmed with the General Department of Vietnam Customs.
Demand Drivers & Market Opportunity
TransData Nexus Omeprazole buyer market intelligence
1Demand Drivers & Market Opportunity
The global demand for Omeprazole is driven by several factors:
1. Prevalence of Gastrointestinal Disorders: Omeprazole is widely used to treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. The increasing incidence of these disorders, linked to lifestyle changes and aging populations, fuels demand.
2. Government Healthcare Programs and Universal Health Coverage: Many countries are expanding healthcare access, incorporating essential medicines like Omeprazole into public health programs. For example, the inclusion of Omeprazole in national formularies ensures its availability to a broader patient base.
3. WHO Essential Medicines List (EML) Procurement: Omeprazole's presence on the WHO EML underscores its importance, prompting governments and international organizations to prioritize its procurement. This inclusion facilitates tender-based purchasing, ensuring consistent supply and affordability.
With 2,858 buyers across 179 countries, the market for Omeprazole imported from India is robust. The repeat buyer rate of 59.0% indicates strong ongoing demand, presenting opportunities for exporters to establish long-term relationships and expand their market presence.
Common Questions — Omeprazole Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest omeprazole buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $54.7M in imports and a 8.6% market share — the highest of any single omeprazole importer. SUN PHARMA CANADA INC. (CANADA) and CIPLAMEDICA PHARMACEUTICAL INDUSTRI (YEMEN) are the next largest buyers.
QHow many companies buy omeprazole from India?
There are 2858 active omeprazole buyers importing from India, with a combined market of $635.6M across 15,000 shipments to 179 countries. The top 5 buyers hold 35.4% of total import value, while the remaining 2853 buyers handle the other 64.6%.
QWhich countries import the most omeprazole from India?
The top importing countries for omeprazole from India are United States (26.0%), Canada (13.5%), Belgium (10.1%), Yemen (8.1%), Vietnam (6.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of omeprazole, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for omeprazole from India?
The average import transaction value for omeprazole from India is $42.4K, with an average unit price of $49.82 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Omeprazole buyer market intelligence
1Buyer Segment Analysis
The 2,858 buyers of Omeprazole from India can be categorized into several segments:
1. Distributors: Entities that purchase Omeprazole in bulk to supply to various healthcare providers and retailers. For instance, YUSEN LOGISTICS BENELUX BELGIUM in Belgium, with imports totaling $54.70 million, likely operates as a distributor, facilitating the movement of pharmaceuticals across regions. Distributors typically place large, periodic orders to maintain a steady supply chain.
2. Pharmaceutical Companies: Manufacturers that import Omeprazole either as an active pharmaceutical ingredient (API) or in finished dosage forms for further processing or direct distribution. Companies like SUN PHARMA CANADA INC. ($53.79 million) and CIPLA USA INC. ($41.14 million) fall into this category. Their procurement patterns are aligned with production schedules and market demand forecasts.
3. Government Procurement Agencies: Organizations responsible for acquiring medicines for public healthcare systems, often through tender-based processes. While specific agencies are not listed among the top buyers, countries like Yemen, with significant imports ($50.02 million by CIPLAMEDICA PHARMACEUTICAL INDUSTRI), may involve government tenders. These buyers typically have stringent quality requirements and may place large, infrequent orders based on public health needs.
4. Contract Manufacturers: Firms that produce pharmaceuticals on behalf of other companies, requiring a steady supply of APIs like Omeprazole. Entities such as MYLAN PHARMACEUTICALS ULC in Canada ($24.28 million) and GLENMARK PHARMACEUTICALS INC., USA ($17.78 million) are indicative of this segment. Their purchasing behavior is closely tied to contractual obligations and production timelines.
Country-Specific Import Regulations
TransData Nexus Omeprazole buyer market intelligence
1Country-Specific Import Regulations
United States
1. Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Omeprazole products comply with FDA regulations, including proper labeling and approval for sale in the U.S. market. Repackaging without appropriate country-of-origin marking can lead to misbranding issues.
3. Estimated Timeline for Registration: The FDA's drug approval process can vary, but for generic drugs, it typically takes 10 months under the Generic Drug User Fee Amendments (GDUFA).
4. Import Tariff/Duty for HS 30049034: Pharmaceutical products under this HS code are generally duty-free in the United States.
Canada
1. Regulatory Authority: Health Canada.
2. Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure products meet the Food and Drug Regulations. In cases of drug shortages, Health Canada may permit exceptional importation and sale of drugs not authorized in Canada. (canada.ca)
3. Estimated Timeline for Registration: The standard review process for generic drugs is approximately 180 days.
4. Import Tariff/Duty for HS 30049034: Pharmaceutical products under this HS code are typically duty-free in Canada.
Belgium
1. Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
2. Import Registration Process: Importers must hold a Wholesale Distribution Authorization and ensure products comply with European Medicines Agency (EMA) standards.
3. Estimated Timeline for Registration: The EMA's centralized procedure takes up to 210 days, but national procedures may vary.
4. Import Tariff/Duty for HS 30049034: As part of the EU, Belgium applies a common external tariff; however, pharmaceutical products are often exempt from duties.
Yemen
1. Regulatory Authority: Supreme Board of Drugs and Medical Appliances (SBDMA).
2. Import Registration Process: Importers must register pharmaceutical products with the SBDMA, providing documentation on quality, safety, and efficacy.
3. Estimated Timeline for Registration: The process can take several months, depending on the completeness of the application and regulatory workload.
4. Import Tariff/Duty for HS 30049034: Specific tariff information is not readily available; importers should consult local customs authorities.
Vietnam
1. Regulatory Authority: Drug Administration of Vietnam (DAV).
2. Import Registration Process: Importers must obtain a Marketing Authorization from the DAV, ensuring compliance with local regulations.
3. Estimated Timeline for Registration: The registration process typically takes 12 to 24 months.
4. Import Tariff/Duty for HS 30049034: Vietnam applies import duties on pharmaceuticals; specific rates should be confirmed with the General Department of Vietnam Customs.
Demand Drivers & Market Opportunity
TransData Nexus Omeprazole buyer market intelligence
1Demand Drivers & Market Opportunity
The global demand for Omeprazole is driven by several factors:
1. Prevalence of Gastrointestinal Disorders: Omeprazole is widely used to treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. The increasing incidence of these disorders, linked to lifestyle changes and aging populations, fuels demand.
2. Government Healthcare Programs and Universal Health Coverage: Many countries are expanding healthcare access, incorporating essential medicines like Omeprazole into public health programs. For example, the inclusion of Omeprazole in national formularies ensures its availability to a broader patient base.
3. WHO Essential Medicines List (EML) Procurement: Omeprazole's presence on the WHO EML underscores its importance, prompting governments and international organizations to prioritize its procurement. This inclusion facilitates tender-based purchasing, ensuring consistent supply and affordability.
With 2,858 buyers across 179 countries, the market for Omeprazole imported from India is robust. The repeat buyer rate of 59.0% indicates strong ongoing demand, presenting opportunities for exporters to establish long-term relationships and expand their market presence.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 2858 global importers of Omeprazole identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 179 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
2858 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists